APO Research
Talk to an analyst

APO RESEARCH · REPORT

Serum and Plasma Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Serum and Plasma Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026190 pages

Choose your research edition.

Industry ResearchSerum and Plasma Proteomics Service Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Serum and Plasma Proteomics Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Serum and Plasma Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Serum and Plasma Proteomics Service Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Serum and Plasma Proteomics Service Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Serum and Plasma Proteomics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Serum and Plasma Proteomics Service include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Serum and Plasma Proteomics Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Serum and Plasma Proteomics Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Serum and Plasma Proteomics Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Serum and Plasma Proteomics Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Serum and Plasma Proteomics Service Segment by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Serum and Plasma Proteomics Service Segment by Type

Plasma Proteomics Analysis Service

Serum Proteomics Analysis Service

Serum and Plasma Proteomics Service Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Serum and Plasma Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serum and Plasma Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Serum and Plasma Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serum and Plasma Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Serum and Plasma Proteomics Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Serum and Plasma Proteomics Service industry.

Chapter 3: Detailed analysis of Serum and Plasma Proteomics Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Serum and Plasma Proteomics Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Serum and Plasma Proteomics Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Plasma Proteomics Analysis Service Table 3. Key Players of Serum Proteomics Analysis Service Table 4. Global Serum and Plasma Proteomics Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Disease Biomarker Research Table 6. Key Players of Drug Development Table 7. Key Players of Clinical Research Table 8. Key Players of Others Table 9. Global Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Serum and Plasma Proteomics Service Market Share by Region (2021-2026) Table 12. Global Serum and Plasma Proteomics Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Serum and Plasma Proteomics Service Market Share by Region (2027-2032) Table 14. Serum and Plasma Proteomics Service Industry Trends Table 15. Serum and Plasma Proteomics Service Industry Drivers Table 16. Serum and Plasma Proteomics Service Industry Opportunities and Challenges Table 17. Serum and Plasma Proteomics Service Industry Restraints Table 18. Global Serum and Plasma Proteomics Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Serum and Plasma Proteomics Service Revenue Market Share by Company (2021-2026) Table 20. Global Serum and Plasma Proteomics Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Serum and Plasma Proteomics Service Key Company Head Office and Area Served Table 22. Global Serum and Plasma Proteomics Service Company, Product Type & Application Table 23. Global Serum and Plasma Proteomics Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Serum and Plasma Proteomics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Serum and Plasma Proteomics Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Serum and Plasma Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Serum and Plasma Proteomics Service Revenue Market Share by Type (2021-2026) Table 30. Global Serum and Plasma Proteomics Service Revenue Market Share by Type (2027-2032) Table 31. Global Serum and Plasma Proteomics Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Serum and Plasma Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Serum and Plasma Proteomics Service Revenue Market Share by Application (2021-2026) Table 35. Global Serum and Plasma Proteomics Service Revenue Market Share by Application (2027-2032) Table 36. BostonGene Company Information Table 37. BostonGene Business Overview Table 38. BostonGene Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. BostonGene Serum and Plasma Proteomics Service Product Portfolio Table 40. BostonGene Recent Development Table 41. CellCarta Company Information Table 42. CellCarta Business Overview Table 43. CellCarta Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. CellCarta Serum and Plasma Proteomics Service Product Portfolio Table 45. CellCarta Recent Development Table 46. GENEWIZ (Azenta Life Sciences) Company Information Table 47. GENEWIZ (Azenta Life Sciences) Business Overview Table 48. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Portfolio Table 50. GENEWIZ (Azenta Life Sciences) Recent Development Table 51. CDI Labs Company Information Table 52. CDI Labs Business Overview Table 53. CDI Labs Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. CDI Labs Serum and Plasma Proteomics Service Product Portfolio Table 55. CDI Labs Recent Development Table 56. Biognosys Company Information Table 57. Biognosys Business Overview Table 58. Biognosys Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Biognosys Serum and Plasma Proteomics Service Product Portfolio Table 60. Biognosys Recent Development Table 61. Discovery Life Sciences Company Information Table 62. Discovery Life Sciences Business Overview Table 63. Discovery Life Sciences Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Discovery Life Sciences Serum and Plasma Proteomics Service Product Portfolio Table 65. Discovery Life Sciences Recent Development Table 66. Firalis Molecular Precision Company Information Table 67. Firalis Molecular Precision Business Overview Table 68. Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Firalis Molecular Precision Serum and Plasma Proteomics Service Product Portfolio Table 70. Firalis Molecular Precision Recent Development Table 71. Cell Signaling Technology (CST) Company Information Table 72. Cell Signaling Technology (CST) Business Overview Table 73. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Portfolio Table 75. Cell Signaling Technology (CST) Recent Development Table 76. Sampled (Infinity Biologix) Company Information Table 77. Sampled (Infinity Biologix) Business Overview Table 78. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Portfolio Table 80. Sampled (Infinity Biologix) Recent Development Table 81. APTBIO Company Information Table 82. APTBIO Business Overview Table 83. APTBIO Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. APTBIO Serum and Plasma Proteomics Service Product Portfolio Table 85. APTBIO Recent Development Table 86. Sinotech Genomics Company Information Table 87. Sinotech Genomics Business Overview Table 88. Sinotech Genomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Sinotech Genomics Serum and Plasma Proteomics Service Product Portfolio Table 90. Sinotech Genomics Recent Development Table 91. Biodesix Company Information Table 92. Biodesix Business Overview Table 93. Biodesix Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Biodesix Serum and Plasma Proteomics Service Product Portfolio Table 95. Biodesix Recent Development Table 96. Panome Bio Company Information Table 97. Panome Bio Business Overview Table 98. Panome Bio Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Panome Bio Serum and Plasma Proteomics Service Product Portfolio Table 100. Panome Bio Recent Development Table 101. Novogene Company Information Table 102. Novogene Business Overview Table 103. Novogene Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Novogene Serum and Plasma Proteomics Service Product Portfolio Table 105. Novogene Recent Development Table 106. PTM BIO Company Information Table 107. PTM BIO Business Overview Table 108. PTM BIO Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. PTM BIO Serum and Plasma Proteomics Service Product Portfolio Table 110. PTM BIO Recent Development Table 111. BGI Genomics Company Information Table 112. BGI Genomics Business Overview Table 113. BGI Genomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. BGI Genomics Serum and Plasma Proteomics Service Product Portfolio Table 115. BGI Genomics Recent Development Table 116. Evotec Company Information Table 117. Evotec Business Overview Table 118. Evotec Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Evotec Serum and Plasma Proteomics Service Product Portfolio Table 120. Evotec Recent Development Table 121. Metware Biotechnology Company Information Table 122. Metware Biotechnology Business Overview Table 123. Metware Biotechnology Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Metware Biotechnology Serum and Plasma Proteomics Service Product Portfolio Table 125. Metware Biotechnology Recent Development Table 126. MRM Proteomics Company Information Table 127. MRM Proteomics Business Overview Table 128. MRM Proteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. MRM Proteomics Serum and Plasma Proteomics Service Product Portfolio Table 130. MRM Proteomics Recent Development Table 131. Lc-Bio Technologies Company Information Table 132. Lc-Bio Technologies Business Overview Table 133. Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Lc-Bio Technologies Serum and Plasma Proteomics Service Product Portfolio Table 135. Lc-Bio Technologies Recent Development Table 136. Eurofins Scientific Company Information Table 137. Eurofins Scientific Business Overview Table 138. Eurofins Scientific Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Eurofins Scientific Serum and Plasma Proteomics Service Product Portfolio Table 140. Eurofins Scientific Recent Development Table 141. MtoZ-Biolabs Company Information Table 142. MtoZ-Biolabs Business Overview Table 143. MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 144. MtoZ-Biolabs Serum and Plasma Proteomics Service Product Portfolio Table 145. MtoZ-Biolabs Recent Development Table 146. Creative Proteomics Company Information Table 147. Creative Proteomics Business Overview Table 148. Creative Proteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 149. Creative Proteomics Serum and Plasma Proteomics Service Product Portfolio Table 150. Creative Proteomics Recent Development Table 151. Macrogen Company Information Table 152. Macrogen Business Overview Table 153. Macrogen Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 154. Macrogen Serum and Plasma Proteomics Service Product Portfolio Table 155. Macrogen Recent Development Table 156. TATAA Biocenter Company Information Table 157. TATAA Biocenter Business Overview Table 158. TATAA Biocenter Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 159. TATAA Biocenter Serum and Plasma Proteomics Service Product Portfolio Table 160. TATAA Biocenter Recent Development Table 161. OmicScouts (Momentum Biotechnologies) Company Information Table 162. OmicScouts (Momentum Biotechnologies) Business Overview Table 163. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 164. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Portfolio Table 165. OmicScouts (Momentum Biotechnologies) Recent Development Table 166. Precision Biomarker Laboratories (PBL) Company Information Table 167. Precision Biomarker Laboratories (PBL) Business Overview Table 168. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 169. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Portfolio Table 170. Precision Biomarker Laboratories (PBL) Recent Development Table 171. Shanghai OE Biotech Company Information Table 172. Shanghai OE Biotech Business Overview Table 173. Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 174. Shanghai OE Biotech Serum and Plasma Proteomics Service Product Portfolio Table 175. Shanghai OE Biotech Recent Development Table 176. RxCelerate Company Information Table 177. RxCelerate Business Overview Table 178. RxCelerate Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 179. RxCelerate Serum and Plasma Proteomics Service Product Portfolio Table 180. RxCelerate Recent Development Table 181. Proteomics International Company Information Table 182. Proteomics International Business Overview Table 183. Proteomics International Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 184. Proteomics International Serum and Plasma Proteomics Service Product Portfolio Table 185. Proteomics International Recent Development Table 186. Proteome Sciences Company Information Table 187. Proteome Sciences Business Overview Table 188. Proteome Sciences Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 189. Proteome Sciences Serum and Plasma Proteomics Service Product Portfolio Table 190. Proteome Sciences Recent Development Table 191. Westlake Omics Company Information Table 192. Westlake Omics Business Overview Table 193. Westlake Omics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 194. Westlake Omics Serum and Plasma Proteomics Service Product Portfolio Table 195. Westlake Omics Recent Development Table 196. Crown Bioscience Company Information Table 197. Crown Bioscience Business Overview Table 198. Crown Bioscience Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 199. Crown Bioscience Serum and Plasma Proteomics Service Product Portfolio Table 200. Crown Bioscience Recent Development Table 201. VProteomics Company Information Table 202. VProteomics Business Overview Table 203. VProteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 204. VProteomics Serum and Plasma Proteomics Service Product Portfolio Table 205. VProteomics Recent Development Table 206. Shanghai Majorbio Bio-Pharm Company Information Table 207. Shanghai Majorbio Bio-Pharm Business Overview Table 208. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 209. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Portfolio Table 210. Shanghai Majorbio Bio-Pharm Recent Development Table 211. Applied Biomics Company Information Table 212. Applied Biomics Business Overview Table 213. Applied Biomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 214. Applied Biomics Serum and Plasma Proteomics Service Product Portfolio Table 215. Applied Biomics Recent Development Table 216. Sapient Bioanalytics Company Information Table 217. Sapient Bioanalytics Business Overview Table 218. Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 219. Sapient Bioanalytics Serum and Plasma Proteomics Service Product Portfolio Table 220. Sapient Bioanalytics Recent Development Table 221. Allumiqs Company Information Table 222. Allumiqs Business Overview Table 223. Allumiqs Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 224. Allumiqs Serum and Plasma Proteomics Service Product Portfolio Table 225. Allumiqs Recent Development Table 226. MS Bioworks Company Information Table 227. MS Bioworks Business Overview Table 228. MS Bioworks Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 229. MS Bioworks Serum and Plasma Proteomics Service Product Portfolio Table 230. MS Bioworks Recent Development Table 231. Shanghai Bioprofile Company Information Table 232. Shanghai Bioprofile Business Overview Table 233. Shanghai Bioprofile Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 234. Shanghai Bioprofile Serum and Plasma Proteomics Service Product Portfolio Table 235. Shanghai Bioprofile Recent Development Table 236. North America Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 237. North America Serum and Plasma Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 238. North America Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 239. North America Serum and Plasma Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 240. North America Serum and Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. North America Serum and Plasma Proteomics Service Market Size by Country (2021-2026) Table 242. North America Serum and Plasma Proteomics Service Market Size by Country (2027-2032) Table 243. Europe Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 244. Europe Serum and Plasma Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 245. Europe Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 246. Europe Serum and Plasma Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 247. Europe Serum and Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026) Table 249. Europe Serum and Plasma Proteomics Service Market Size by Country (2027-2032) Table 250. China Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 251. China Serum and Plasma Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 252. China Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 253. China Serum and Plasma Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 254. Asia Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 255. Asia Serum and Plasma Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 256. Asia Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 257. Asia Serum and Plasma Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 258. Asia Serum and Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 259. Asia Serum and Plasma Proteomics Service Market Size by Country (2021-2026) Table 260. Asia Serum and Plasma Proteomics Service Market Size by Country (2027-2032) Table 261. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 262. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 263. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 264. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 265. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 266. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2021-2026) Table 267. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2027-2032) Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Serum and Plasma Proteomics Service Product Image Figure 2. Global Serum and Plasma Proteomics Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Serum and Plasma Proteomics Service Market Share by Type: 2025 VS 2032 Figure 4. Plasma Proteomics Analysis Service Image Figure 5. Serum Proteomics Analysis Service Image Figure 6. Global Serum and Plasma Proteomics Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Serum and Plasma Proteomics Service Market Share by Application: 2025 VS 2032 Figure 8. Disease Biomarker Research Image Figure 9. Drug Development Image Figure 10. Clinical Research Image Figure 11. Others Image Figure 12. Global Serum and Plasma Proteomics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 14. Global Serum and Plasma Proteomics Service Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Serum and Plasma Proteomics Service Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Serum and Plasma Proteomics Service Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Serum and Plasma Proteomics Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Serum and Plasma Proteomics Service Revenue Market Share by Type (2021-2032) Figure 21. Global Serum and Plasma Proteomics Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Serum and Plasma Proteomics Service Revenue Market Share by Application (2021-2032) Figure 23. North America Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 24. North America Serum and Plasma Proteomics Service Market Share by Type (2021-2032) Figure 25. North America Serum and Plasma Proteomics Service Market Share by Application (2021-2032) Figure 26. North America Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 27. United States Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 28. Canada Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 30. Europe Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Serum and Plasma Proteomics Service Market Share by Type (2021-2032) Figure 32. Europe Serum and Plasma Proteomics Service Market Share by Application (2021-2032) Figure 33. Europe Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 34. Germany Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 35. France Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 37. Italy Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 38. Russia Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 40. China Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 41. China Serum and Plasma Proteomics Service Market Share by Type (2021-2032) Figure 42. China Serum and Plasma Proteomics Service Market Share by Application (2021-2032) Figure 43. Asia Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 44. Asia Serum and Plasma Proteomics Service Market Share by Type (2021-2032) Figure 45. Asia Serum and Plasma Proteomics Service Market Share by Application (2021-2032) Figure 46. Asia Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 47. Japan Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 51. India Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 52. Australia Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 57. Brazil Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 62. UAE Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 64. Chile Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma Proteomics Analysis Service
  • Serum Proteomics Analysis Service
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Serum and Plasma Proteomics Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Plasma Proteomics Analysis Service
  5. 1.2.3 Serum Proteomics Analysis Service
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Serum and Plasma Proteomics Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Disease Biomarker Research
  9. 1.3.3 Drug Development
  10. 1.3.4 Clinical Research
  11. 1.3.5 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Serum and Plasma Proteomics Service Growth Trends by Region
  14. 1.5.1 Global Serum and Plasma Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Serum and Plasma Proteomics Service Market Size by Region (2021-2026)
  16. 1.5.3 Serum and Plasma Proteomics Service Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Serum and Plasma Proteomics Service Market Dynamics
  1. 2.1 Serum and Plasma Proteomics Service Industry Trends
  2. 2.2 Serum and Plasma Proteomics Service Industry Drivers
  3. 2.3 Serum and Plasma Proteomics Service Industry Opportunities and Challenges
  4. 2.4 Serum and Plasma Proteomics Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Serum and Plasma Proteomics Service Revenue by Company (2021-2026)
  2. 3.2 Global Serum and Plasma Proteomics Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Serum and Plasma Proteomics Service Key Company Head office and Area Served
  4. 3.4 Global Serum and Plasma Proteomics Service Company, Product Type & Application
  5. 3.5 Global Serum and Plasma Proteomics Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Serum and Plasma Proteomics Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Serum and Plasma Proteomics Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Serum and Plasma Proteomics Service Tier 1, Tier 2, and Tier 3
4 Serum and Plasma Proteomics Service Market by Type
  1. 4.1 Global Serum and Plasma Proteomics Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Serum and Plasma Proteomics Service Market Size by Type (2021-2032)
  3. 4.3 Global Serum and Plasma Proteomics Service Market Size Share by Type (2021-2032)
5 Serum and Plasma Proteomics Service Market by Application
  1. 5.1 Global Serum and Plasma Proteomics Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Serum and Plasma Proteomics Service Market Size by Application (2021-2032)
  3. 5.3 Global Serum and Plasma Proteomics Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BostonGene
  2. 6.1.1 BostonGene Company Information
  3. 6.1.2 BostonGene Business Overview
  4. 6.1.3 BostonGene Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 BostonGene Serum and Plasma Proteomics Service Product Portfolio
  6. 6.1.5 BostonGene Recent Developments
  7. 6.2 CellCarta
  8. 6.2.1 CellCarta Company Information
  9. 6.2.2 CellCarta Business Overview
  10. 6.2.3 CellCarta Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 CellCarta Serum and Plasma Proteomics Service Product Portfolio
  12. 6.2.5 CellCarta Recent Developments
  13. 6.3 GENEWIZ (Azenta Life Sciences)
  14. 6.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 6.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 6.3.3 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Portfolio
  18. 6.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 6.4 CDI Labs
  20. 6.4.1 CDI Labs Company Information
  21. 6.4.2 CDI Labs Business Overview
  22. 6.4.3 CDI Labs Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 CDI Labs Serum and Plasma Proteomics Service Product Portfolio
  24. 6.4.5 CDI Labs Recent Developments
  25. 6.5 Biognosys
  26. 6.5.1 Biognosys Company Information
  27. 6.5.2 Biognosys Business Overview
  28. 6.5.3 Biognosys Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Biognosys Serum and Plasma Proteomics Service Product Portfolio
  30. 6.5.5 Biognosys Recent Developments
  31. 6.6 Discovery Life Sciences
  32. 6.6.1 Discovery Life Sciences Company Information
  33. 6.6.2 Discovery Life Sciences Business Overview
  34. 6.6.3 Discovery Life Sciences Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Discovery Life Sciences Serum and Plasma Proteomics Service Product Portfolio
  36. 6.6.5 Discovery Life Sciences Recent Developments
  37. 6.7 Firalis Molecular Precision
  38. 6.7.1 Firalis Molecular Precision Company Information
  39. 6.7.2 Firalis Molecular Precision Business Overview
  40. 6.7.3 Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Firalis Molecular Precision Serum and Plasma Proteomics Service Product Portfolio
  42. 6.7.5 Firalis Molecular Precision Recent Developments
  43. 6.8 Cell Signaling Technology (CST)
  44. 6.8.1 Cell Signaling Technology (CST) Company Information
  45. 6.8.2 Cell Signaling Technology (CST) Business Overview
  46. 6.8.3 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Portfolio
  48. 6.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 6.9 Sampled (Infinity Biologix)
  50. 6.9.1 Sampled (Infinity Biologix) Company Information
  51. 6.9.2 Sampled (Infinity Biologix) Business Overview
  52. 6.9.3 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Portfolio
  54. 6.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 6.10 APTBIO
  56. 6.10.1 APTBIO Company Information
  57. 6.10.2 APTBIO Business Overview
  58. 6.10.3 APTBIO Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 APTBIO Serum and Plasma Proteomics Service Product Portfolio
  60. 6.10.5 APTBIO Recent Developments
  61. 6.11 Sinotech Genomics
  62. 6.11.1 Sinotech Genomics Company Information
  63. 6.11.2 Sinotech Genomics Business Overview
  64. 6.11.3 Sinotech Genomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sinotech Genomics Serum and Plasma Proteomics Service Product Portfolio
  66. 6.11.5 Sinotech Genomics Recent Developments
  67. 6.12 Biodesix
  68. 6.12.1 Biodesix Company Information
  69. 6.12.2 Biodesix Business Overview
  70. 6.12.3 Biodesix Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Biodesix Serum and Plasma Proteomics Service Product Portfolio
  72. 6.12.5 Biodesix Recent Developments
  73. 6.13 Panome Bio
  74. 6.13.1 Panome Bio Company Information
  75. 6.13.2 Panome Bio Business Overview
  76. 6.13.3 Panome Bio Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Panome Bio Serum and Plasma Proteomics Service Product Portfolio
  78. 6.13.5 Panome Bio Recent Developments
  79. 6.14 Novogene
  80. 6.14.1 Novogene Company Information
  81. 6.14.2 Novogene Business Overview
  82. 6.14.3 Novogene Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Novogene Serum and Plasma Proteomics Service Product Portfolio
  84. 6.14.5 Novogene Recent Developments
  85. 6.15 PTM BIO
  86. 6.15.1 PTM BIO Company Information
  87. 6.15.2 PTM BIO Business Overview
  88. 6.15.3 PTM BIO Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 PTM BIO Serum and Plasma Proteomics Service Product Portfolio
  90. 6.15.5 PTM BIO Recent Developments
  91. 6.16 BGI Genomics
  92. 6.16.1 BGI Genomics Company Information
  93. 6.16.2 BGI Genomics Business Overview
  94. 6.16.3 BGI Genomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 BGI Genomics Serum and Plasma Proteomics Service Product Portfolio
  96. 6.16.5 BGI Genomics Recent Developments
  97. 6.17 Evotec
  98. 6.17.1 Evotec Company Information
  99. 6.17.2 Evotec Business Overview
  100. 6.17.3 Evotec Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Evotec Serum and Plasma Proteomics Service Product Portfolio
  102. 6.17.5 Evotec Recent Developments
  103. 6.18 Metware Biotechnology
  104. 6.18.1 Metware Biotechnology Company Information
  105. 6.18.2 Metware Biotechnology Business Overview
  106. 6.18.3 Metware Biotechnology Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Metware Biotechnology Serum and Plasma Proteomics Service Product Portfolio
  108. 6.18.5 Metware Biotechnology Recent Developments
  109. 6.19 MRM Proteomics
  110. 6.19.1 MRM Proteomics Company Information
  111. 6.19.2 MRM Proteomics Business Overview
  112. 6.19.3 MRM Proteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 MRM Proteomics Serum and Plasma Proteomics Service Product Portfolio
  114. 6.19.5 MRM Proteomics Recent Developments
  115. 6.20 Lc-Bio Technologies
  116. 6.20.1 Lc-Bio Technologies Company Information
  117. 6.20.2 Lc-Bio Technologies Business Overview
  118. 6.20.3 Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Lc-Bio Technologies Serum and Plasma Proteomics Service Product Portfolio
  120. 6.20.5 Lc-Bio Technologies Recent Developments
  121. 6.21 Eurofins Scientific
  122. 6.21.1 Eurofins Scientific Company Information
  123. 6.21.2 Eurofins Scientific Business Overview
  124. 6.21.3 Eurofins Scientific Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Eurofins Scientific Serum and Plasma Proteomics Service Product Portfolio
  126. 6.21.5 Eurofins Scientific Recent Developments
  127. 6.22 MtoZ-Biolabs
  128. 6.22.1 MtoZ-Biolabs Company Information
  129. 6.22.2 MtoZ-Biolabs Business Overview
  130. 6.22.3 MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 MtoZ-Biolabs Serum and Plasma Proteomics Service Product Portfolio
  132. 6.22.5 MtoZ-Biolabs Recent Developments
  133. 6.23 Creative Proteomics
  134. 6.23.1 Creative Proteomics Company Information
  135. 6.23.2 Creative Proteomics Business Overview
  136. 6.23.3 Creative Proteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Creative Proteomics Serum and Plasma Proteomics Service Product Portfolio
  138. 6.23.5 Creative Proteomics Recent Developments
  139. 6.24 Macrogen
  140. 6.24.1 Macrogen Company Information
  141. 6.24.2 Macrogen Business Overview
  142. 6.24.3 Macrogen Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Macrogen Serum and Plasma Proteomics Service Product Portfolio
  144. 6.24.5 Macrogen Recent Developments
  145. 6.25 TATAA Biocenter
  146. 6.25.1 TATAA Biocenter Company Information
  147. 6.25.2 TATAA Biocenter Business Overview
  148. 6.25.3 TATAA Biocenter Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 TATAA Biocenter Serum and Plasma Proteomics Service Product Portfolio
  150. 6.25.5 TATAA Biocenter Recent Developments
  151. 6.26 OmicScouts (Momentum Biotechnologies)
  152. 6.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 6.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 6.26.3 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Portfolio
  156. 6.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 6.27 Precision Biomarker Laboratories (PBL)
  158. 6.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 6.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 6.27.3 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  161. 6.27.4 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Portfolio
  162. 6.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 6.28 Shanghai OE Biotech
  164. 6.28.1 Shanghai OE Biotech Company Information
  165. 6.28.2 Shanghai OE Biotech Business Overview
  166. 6.28.3 Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  167. 6.28.4 Shanghai OE Biotech Serum and Plasma Proteomics Service Product Portfolio
  168. 6.28.5 Shanghai OE Biotech Recent Developments
  169. 6.29 RxCelerate
  170. 6.29.1 RxCelerate Company Information
  171. 6.29.2 RxCelerate Business Overview
  172. 6.29.3 RxCelerate Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  173. 6.29.4 RxCelerate Serum and Plasma Proteomics Service Product Portfolio
  174. 6.29.5 RxCelerate Recent Developments
  175. 6.30 Proteomics International
  176. 6.30.1 Proteomics International Company Information
  177. 6.30.2 Proteomics International Business Overview
  178. 6.30.3 Proteomics International Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  179. 6.30.4 Proteomics International Serum and Plasma Proteomics Service Product Portfolio
  180. 6.30.5 Proteomics International Recent Developments
  181. 6.31 Proteome Sciences
  182. 6.31.1 Proteome Sciences Company Information
  183. 6.31.2 Proteome Sciences Business Overview
  184. 6.31.3 Proteome Sciences Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  185. 6.31.4 Proteome Sciences Serum and Plasma Proteomics Service Product Portfolio
  186. 6.31.5 Proteome Sciences Recent Developments
  187. 6.32 Westlake Omics
  188. 6.32.1 Westlake Omics Company Information
  189. 6.32.2 Westlake Omics Business Overview
  190. 6.32.3 Westlake Omics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  191. 6.32.4 Westlake Omics Serum and Plasma Proteomics Service Product Portfolio
  192. 6.32.5 Westlake Omics Recent Developments
  193. 6.33 Crown Bioscience
  194. 6.33.1 Crown Bioscience Company Information
  195. 6.33.2 Crown Bioscience Business Overview
  196. 6.33.3 Crown Bioscience Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  197. 6.33.4 Crown Bioscience Serum and Plasma Proteomics Service Product Portfolio
  198. 6.33.5 Crown Bioscience Recent Developments
  199. 6.34 VProteomics
  200. 6.34.1 VProteomics Company Information
  201. 6.34.2 VProteomics Business Overview
  202. 6.34.3 VProteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  203. 6.34.4 VProteomics Serum and Plasma Proteomics Service Product Portfolio
  204. 6.34.5 VProteomics Recent Developments
  205. 6.35 Shanghai Majorbio Bio-Pharm
  206. 6.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 6.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 6.35.3 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  209. 6.35.4 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Portfolio
  210. 6.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 6.36 Applied Biomics
  212. 6.36.1 Applied Biomics Company Information
  213. 6.36.2 Applied Biomics Business Overview
  214. 6.36.3 Applied Biomics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  215. 6.36.4 Applied Biomics Serum and Plasma Proteomics Service Product Portfolio
  216. 6.36.5 Applied Biomics Recent Developments
  217. 6.37 Sapient Bioanalytics
  218. 6.37.1 Sapient Bioanalytics Company Information
  219. 6.37.2 Sapient Bioanalytics Business Overview
  220. 6.37.3 Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  221. 6.37.4 Sapient Bioanalytics Serum and Plasma Proteomics Service Product Portfolio
  222. 6.37.5 Sapient Bioanalytics Recent Developments
  223. 6.38 Allumiqs
  224. 6.38.1 Allumiqs Company Information
  225. 6.38.2 Allumiqs Business Overview
  226. 6.38.3 Allumiqs Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  227. 6.38.4 Allumiqs Serum and Plasma Proteomics Service Product Portfolio
  228. 6.38.5 Allumiqs Recent Developments
  229. 6.39 MS Bioworks
  230. 6.39.1 MS Bioworks Company Information
  231. 6.39.2 MS Bioworks Business Overview
  232. 6.39.3 MS Bioworks Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  233. 6.39.4 MS Bioworks Serum and Plasma Proteomics Service Product Portfolio
  234. 6.39.5 MS Bioworks Recent Developments
  235. 6.40 Shanghai Bioprofile
  236. 6.40.1 Shanghai Bioprofile Company Information
  237. 6.40.2 Shanghai Bioprofile Business Overview
  238. 6.40.3 Shanghai Bioprofile Serum and Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  239. 6.40.4 Shanghai Bioprofile Serum and Plasma Proteomics Service Product Portfolio
  240. 6.40.5 Shanghai Bioprofile Recent Developments
  241. 6.41 Cosmos Wisdom
  242. 6.42 Olink (Thermo Fisher Scientific)
  243. 6.43 SomaLogic (Illumina)
  244. 6.44 Labcorp
7 North America
  1. 7.1 North America Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 7.2 North America Serum and Plasma Proteomics Service Market Size by Type
  3. 7.2.1 North America Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Serum and Plasma Proteomics Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Serum and Plasma Proteomics Service Market Share by Type (2021-2032)
  6. 7.3 North America Serum and Plasma Proteomics Service Market Size by Application
  7. 7.3.1 North America Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Serum and Plasma Proteomics Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Serum and Plasma Proteomics Service Market Share by Application (2021-2032)
  10. 7.4 North America Serum and Plasma Proteomics Service Market Size by Country
  11. 7.4.1 North America Serum and Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Serum and Plasma Proteomics Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 8.2 Europe Serum and Plasma Proteomics Service Market Size by Type
  3. 8.2.1 Europe Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Serum and Plasma Proteomics Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Serum and Plasma Proteomics Service Market Share by Type (2021-2032)
  6. 8.3 Europe Serum and Plasma Proteomics Service Market Size by Application
  7. 8.3.1 Europe Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Serum and Plasma Proteomics Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Serum and Plasma Proteomics Service Market Share by Application (2021-2032)
  10. 8.4 Europe Serum and Plasma Proteomics Service Market Size by Country
  11. 8.4.1 Europe Serum and Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Serum and Plasma Proteomics Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 9.2 China Serum and Plasma Proteomics Service Market Size by Type
  3. 9.2.1 China Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
  4. 9.2.2 China Serum and Plasma Proteomics Service Market Size by Type (2027-2032)
  5. 9.2.3 China Serum and Plasma Proteomics Service Market Share by Type (2021-2032)
  6. 9.3 China Serum and Plasma Proteomics Service Market Size by Application
  7. 9.3.1 China Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
  8. 9.3.2 China Serum and Plasma Proteomics Service Market Size by Application (2027-2032)
  9. 9.3.3 China Serum and Plasma Proteomics Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 10.2 Asia Serum and Plasma Proteomics Service Market Size by Type
  3. 10.2.1 Asia Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Serum and Plasma Proteomics Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Serum and Plasma Proteomics Service Market Share by Type (2021-2032)
  6. 10.3 Asia Serum and Plasma Proteomics Service Market Size by Application
  7. 10.3.1 Asia Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Serum and Plasma Proteomics Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Serum and Plasma Proteomics Service Market Share by Application (2021-2032)
  10. 10.4 Asia Serum and Plasma Proteomics Service Market Size by Country
  11. 10.4.1 Asia Serum and Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Serum and Plasma Proteomics Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Serum and Plasma Proteomics Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst